Efficacy and Safety of Crisaborole Ointment, 2%, for the Treatment of Mild-to-Moderate Atopic Dermatitis Across Racial and Ethnic Groups

BACKGROUND: Atopic dermatitis is highly prevalent in black/African American, Asian, and Hispanic patients, making assessment of these populations in clinical trials important. Crisaborole ointment, 2%, is a nonsteroidal phosphodiesterase 4 inhibitor for the treatment of mild-to-moderate atopic derma...

Descripción completa

Detalles Bibliográficos
Autores principales: Callender, Valerie D., Alexis, Andrew F., Stein Gold, Linda F., Lebwohl, Mark G., Paller, Amy S., Desai, Seemal R., Tan, Huaming, Ports, William C., Zielinski, Michael A., Tallman, Anna M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764931/
https://www.ncbi.nlm.nih.gov/pubmed/31264114
http://dx.doi.org/10.1007/s40257-019-00450-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764931/
https://www.ncbi.nlm.nih.gov/pubmed/31264114
http://dx.doi.org/10.1007/s40257-019-00450-w

Ejemplares similares